Fei-yu Niu

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.

A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.

Journal: Hepatology international

Published: April 22, 2022

Increased MCL-1 synthesis promotes irradiation-induced nasopharyngeal carcinoma radioresistance via regulation of the ROS/AKT loop.

Increased MCL-1 synthesis promotes irradiation-induced nasopharyngeal carcinoma radioresistance via regulation of the ROS/AKT loop.

Journal: Cell death & disease

Published: July 09, 2021

Urokinase plasminogen activator predicts poor prognosis in hepatocellular carcinoma.

Urokinase plasminogen activator predicts poor prognosis in hepatocellular carcinoma.

Journal: Journal of gastrointestinal oncology

Published: May 31, 2021

A Higher Proportion of the EGFR T790M Mutation May Contribute to the Better Survival of Patients with Exon 19 Deletions Compared with Those with L858R.

A Higher Proportion of the EGFR T790M Mutation May Contribute to the Better Survival of Patients with Exon 19 Deletions Compared with Those with L858R.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: April 08, 2017

Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study.

Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study.

Journal: World journal of surgical oncology

Published: February 21, 2016

Predictive and prognostic value of de novo MET expression in patients with advanced non-small-cell lung cancer.

Predictive and prognostic value of de novo MET expression in patients with advanced non-small-cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 12, 2015

Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinib.

Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinib.

Journal: OncoTargets and therapy

Published: May 23, 2015

Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population.

Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population.

Journal: Cancer

Published: April 29, 2015

Multiple primary malignancies involving lung cancer.

Multiple primary malignancies involving lung cancer.

Journal: BMC cancer

Published: January 07, 2015

Distribution and prognosis of uncommon metastases from non-small cell lung cancer.

Distribution and prognosis of uncommon metastases from non-small cell lung cancer.

Journal: BMC cancer

Published: December 22, 2014

Clinical trials for lung cancer in China.

Clinical trials for lung cancer in China.

Journal: Translational lung cancer research

Published: August 21, 2014

Reduced chemotherapy sensitivity in EGFR-mutant lung cancer patient with frontline EGFR tyrosine kinase inhibitor.

Reduced chemotherapy sensitivity in EGFR-mutant lung cancer patient with frontline EGFR tyrosine kinase inhibitor.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 27, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026